Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Panitch

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Pediatrics|November 1, 1996
Pepper-spray-induced respiratory failure treated with extracorporeal membrane oxygenationD F Billmire, C Vinocur, M Ginda, et al.
Journal of Neuroimmunology|March 8, 2005
Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosisJ Graber, M Zhan, D Ford, et al.
Neurology|November 27, 2002
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE TrialH Panitch, D S Goodin, G Francis, et al.
Journal of Neurology|October 16, 2008
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MSD L Arnold, D Campagnolo, H Panitch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2008
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosisT Vollmer, H Panitch, A Bar-Or, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 29, 2010
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetateC Ford, A D Goodman, K Johnson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2009
Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?A Bar-Or, J Oger, E Gibbs, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 23, 2008
Differential diagnosis of suspected multiple sclerosis: a consensus approachD H Miller, B G Weinshenker, M Filippi, et al.
Neurology|March 26, 2008
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessmentC H Polman, S C Reingold, F Barkhof, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Pediatrics|November 1, 1996
Pepper-spray-induced respiratory failure treated with extracorporeal membrane oxygenationD F Billmire, C Vinocur, M Ginda, et al.
Journal of Neuroimmunology|March 8, 2005
Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosisJ Graber, M Zhan, D Ford, et al.
Neurology|November 27, 2002
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE TrialH Panitch, D S Goodin, G Francis, et al.
Journal of Neurology|October 16, 2008
Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MSD L Arnold, D Campagnolo, H Panitch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 22, 2008
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosisT Vollmer, H Panitch, A Bar-Or, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 29, 2010
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetateC Ford, A D Goodman, K Johnson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2009
Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?A Bar-Or, J Oger, E Gibbs, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 23, 2008
Differential diagnosis of suspected multiple sclerosis: a consensus approachD H Miller, B G Weinshenker, M Filippi, et al.
Neurology|March 26, 2008
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessmentC H Polman, S C Reingold, F Barkhof, et al.
Pageof 3